These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31542854)

  • 1. Congenital fibrinogen disorders with repeated thrombosis.
    Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X
    J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia.
    Xiang L; Luo M; Yan J; Liao L; Zhou W; Deng X; Deng D; Cheng P; Lin F
    J Clin Lab Anal; 2018 May; 32(4):e22322. PubMed ID: 28922493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
    Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
    J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.
    Arai S; Kamijo T; Hayashi F; Shinohara S; Arai N; Sugano M; Uehara T; Honda T; Okumura N
    Int J Lab Hematol; 2021 Apr; 43(2):281-289. PubMed ID: 33030793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
    Miesbach W; Schenk J; Alesci S; Lindhoff-Last E
    Thromb Res; 2010 Dec; 126(6):e428-33. PubMed ID: 20947138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
    Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P
    Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Fibrinogen Determination Methods in Differential Diagnosis of Hypofibrinogenemia and Dysfibrinogenemia.
    Skornova I; Simurda T; Stasko J; Horvath D; Zolkova J; Holly P; Brunclikova M; Samos M; Bolek T; Schnierer M; Slavik L; Kubisz P
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel mutations in the fibrinogen γ nodule.
    Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
    Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
    Jacquemin M; Vanlinthout I; Van Horenbeeck I; Debasse M; Toelen J; Schoeters J; Lavend'homme R; Freson K; Peerlinck K
    Int J Lab Hematol; 2017 Jun; 39(3):301-307. PubMed ID: 28318107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature.
    Yan J; Luo M; Xiang L; Wu Y; Lin F
    Clin Chim Acta; 2022 Mar; 528():1-5. PubMed ID: 35063457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
    Miesbach W; Galanakis D; Scharrer I
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogenemia and thrombosis.
    Hayes T
    Arch Pathol Lab Med; 2002 Nov; 126(11):1387-90. PubMed ID: 12421146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory testing for fibrinogen abnormalities.
    Verhovsek M; Moffat KA; Hayward CP
    Am J Hematol; 2008 Dec; 83(12):928-31. PubMed ID: 18951466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe congenital dysfibrinogenemia (fibrinogen-Riyadh): a family study.
    al-Fawaz IM; Gader AM
    Acta Haematol; 1992; 88(4):194-7. PubMed ID: 1292308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications.
    Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO
    Thromb Haemost; 2006 Nov; 96(5):685-7. PubMed ID: 17080227
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
    Li Y; Ding B; Wang X; Ding Q
    Thromb Res; 2022 Sep; 217():36-47. PubMed ID: 35853369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysfibrinogenemia and thrombosis. A case report].
    Kraiem I; Guermazi S; Ben Abid H; Meddeb B
    Tunis Med; 2010 Oct; 88(10):757-60. PubMed ID: 20890827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.